High price and demand for semaglutide means lack of access for US patients
BMJ
.
2023 Aug 30:382:1863.
doi: 10.1136/bmj.p1863.
Author
Carolyn Brown
1
Affiliation
1
Ottawa.
PMID:
37648269
DOI:
10.1136/bmj.p1863
No abstract available
MeSH terms
Glucagon-Like Peptides* / therapeutic use
Humans
Patients*
Substances
semaglutide
Glucagon-Like Peptides